POL HCQ ethics
K |
|||
(15 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
Zeile 1: | Zeile 1: | ||
{{up|Politics main page}} | {{up|Politics main page}} | ||
+ | {{qt|Hydroxychloroquine}} | ||
+ | ---- | ||
+ | hcq has been politicized to be temporary destroyed for clinical applications. discussions and negative study data are presented in this subsection | ||
+ | ---- | ||
+ | |||
+ | *[https://gab.com/DomPachino/posts/105439442464733061 AMA's U-turn after election] | ||
*[https://www.americanthinker.com/blog/2020/12/unexplained_explosion_and_fire_destroy_worlds_second_largest_pharmaceutical_factory_producing_precursors_for_hydroxychloroquine_.html HCQ facility burnt down to ash] | *[https://www.americanthinker.com/blog/2020/12/unexplained_explosion_and_fire_destroy_worlds_second_largest_pharmaceutical_factory_producing_precursors_for_hydroxychloroquine_.html HCQ facility burnt down to ash] | ||
+ | *[https://www.thegatewaypundit.com/2021/01/440000-americans-dead-facebook-american-journal-medicine-admit-stand-hcq-wrong-people-prosecuted/ After 440,000 Americans are Dead – Facebook and American Journal of Medicine Admit Their Stand on HCQ was Wrong — These People Should be Prosecuted!(sic.)] @walkingliberty | ||
+ | *[https://gab.com/OnANeedToKnowBasis/posts/105647420612434315 ruined career docs pro-hcq] | ||
+ | |||
{{tp|p=32279469|t=2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.|pdf=|usr=007}} | {{tp|p=32279469|t=2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.|pdf=|usr=007}} | ||
{{tp|p=32238355|t=2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.|pdf=|usr=007}} | {{tp|p=32238355|t=2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.|pdf=|usr=007}} | ||
Zeile 16: | Zeile 25: | ||
{{tp|p=32881845|t=2020. Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.|pdf=|usr=019}} | {{tp|p=32881845|t=2020. Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.|pdf=|usr=019}} | ||
{{tp|p=32955801|t=2020. Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate.|pdf=|usr=019}} | {{tp|p=32955801|t=2020. Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate.|pdf=|usr=019}} | ||
+ | {{tp|p=33074933|t=2020. Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.|pdf=|usr=020}} | ||
+ | {{tp|p=33077974|t=2020. Latin America's embrace of an unproven COVID treatment is hindering drug trials.|pdf=|usr=020}} | ||
+ | {{tp|p=33088880|t=2020. A stance data set on polarized conversations on Twitter about the efficacy of hydroxychloroquine as a treatment for COVID-19.|pdf=|usr=020}} | ||
+ | {{tp|p=33124746|t=2020. Hydroxychloroquine for coronavirus: how not to repurpose a drug during a pandemic.|pdf=|usr=021}} | ||
+ | {{tp|p=33136577|t=2020. Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility.|pdf=|usr=020}} | ||
+ | {{tp|p=33151895|t=2020. Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study.|pdf=|usr=020}} | ||
+ | {{tp|p=33165507|t=2020. Misguided Use of Hydroxychloroquine for COVID-19: The Infusion of Politics Into Science.|pdf=|usr=020}} | ||
+ | {{tp|p=33197384|t=2020. Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.|pdf=|usr=021}} | ||
+ | {{tp|p=33210338|t=2020. Hydroxychloroquine Controversies: Clinical Trials, Epistemology, and the Democratization of Science.|pdf=|usr=021}} | ||
+ | {{tp|p=33236703|t=2020. The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.|pdf=|usr=021}} | ||
+ | {{tp|p=33243609|t=2020. Hydroxychloroquine for COVID-19: Balancing contrasting claims.|pdf=|usr=022}} | ||
+ | {{tp|p=33254507|t=2020. It is time to drop hydroxychloroquine from our COVID-19 armamentarium.|pdf=|usr=022}} | ||
+ | {{tp|p=33263947|t=2020. Rise and Fall: Hydroxychloroquine and COVID-19 Global Trends: Interest, Political Influence, and Potential Implications.|pdf=|usr=022}} | ||
+ | {{tp|p=33295289|t=2020. Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.|pdf=|usr=022}} | ||
+ | {{tp|p=C7305893|t=?. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.|pdf=|usr=015}} | ||
+ | {{tp|p=C7725088|t=?. Potential harm caused by physicians a-priori beliefs in the clinical effectiveness of hydroxychloroquine and its impact on clinical and economic outcome ? A simulation approach.|pdf=|usr=023}} | ||
+ | {{tp|p=32502485|t=2020. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.|pdf=|usr=015}} | ||
+ | {{tp|p=32506216|t=2020. Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase(R).|pdf=|usr=015}} | ||
+ | {{tp|p=32647045|t=2020. Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making.|pdf=|usr=012}} | ||
+ | {{tp|p=32738852|t=2020. Hydroxychloroquin for COVID-19 Why was so much hype?|pdf=|usr=017}} | ||
+ | {{tp|p=32788309|t=2020. Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter.|pdf=|usr=018}} | ||
+ | {{tp|p=32837201|t=2020. Inefficacite et dangerosite potentielle de l'hydroxychloroquine pour traiter une infection par le coronavirus Sars-cov2.|pdf=|usr=018}} | ||
+ | {{tp|p=32848158|t=2020. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.|pdf=|usr=018}} | ||
+ | {{tp|p=32848774|t=2020. Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use.|pdf=|usr=018}} | ||
+ | {{tp|p=32904117|t=2020. Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety.|pdf=|usr=019}} | ||
+ | {{tp|p=32905939|t=2020. No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials".|pdf=|usr=019}} | ||
+ | {{tp|p=32981089|t=2020. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.|pdf=|usr=019}} | ||
+ | {{tp|p=32740071|t=2020. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.|pdf=|usr=018}} | ||
+ | {{tp|p=32997483|t=2020. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?|pdf=|usr=019}} | ||
+ | {{tp|p=33090972|t=2020. Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.|pdf=|usr=020}} | ||
+ | {{tp|p=33096242|t=2020. Has the door closed on hydroxychloroquine for SARS-COV-2?|pdf=|usr=020}} | ||
+ | {{tp|p=33219663|t=2020. The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.|pdf=|usr=021}} | ||
+ | {{tp|p=33219675|t=2020. Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.|pdf=|usr=021}} | ||
+ | {{tp|p=33221868|t=2020. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.|pdf=|usr=021}} | ||
+ | {{ttp|p=C7298480|t=2020. Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19.|pdf=|usr=015}} | ||
+ | {{tp|p=C7323099|t=?. Hydroxychloroquine for COVID?19: Myths vs Facts.|pdf=|usr=015}} | ||
+ | {{tp|p=33082565|t=2020. HCQ use not protective against SARS-CoV-2.|pdf=|usr=020}} |
Aktuelle Version vom 11. April 2021, 15:32 Uhr
Politics main page |
Hydroxychloroquine |
hcq has been politicized to be temporary destroyed for clinical applications. discussions and negative study data are presented in this subsection
- AMA's U-turn after election
- HCQ facility burnt down to ash
- After 440,000 Americans are Dead – Facebook and American Journal of Medicine Admit Their Stand on HCQ was Wrong — These People Should be Prosecuted!(sic.) @walkingliberty
- ruined career docs pro-hcq
32279469 2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.
32238355 2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.
32294807 2020. Hydroxychloroquine use during the COVID-19 pandemic 2020.
32389025 2020. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
32450097 2020. Prescription Restrictions on Hydroxychloroquine Among the Largest Florida Pharmacy Chains During the COVID-19 Pandemic: An Observational Study.
32451256 2020. COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?
32467095 2020. Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk.
32471832 2020. Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis.
32542496 2020. Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
32620062 2020. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
32662406 2020. Pseudoscience at the expense of rheumatic disease patients during the Coronavirus disease 2019 pandemic.
32738852 2020. Hydroxychloroquin for COVID-19 Why was so much hype?
32875045 2020. L'hydroxy-chloroquine pour traiter les patients infectes du COVID-19: quelques lecons d'an-thropologie medicale et d'histoire de la medecine.
32881845 2020. Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.
32955801 2020. Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate.
33074933 2020. Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.
33077974 2020. Latin America's embrace of an unproven COVID treatment is hindering drug trials.
33088880 2020. A stance data set on polarized conversations on Twitter about the efficacy of hydroxychloroquine as a treatment for COVID-19.
33124746 2020. Hydroxychloroquine for coronavirus: how not to repurpose a drug during a pandemic.
33136577 2020. Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility.
33151895 2020. Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study.
33165507 2020. Misguided Use of Hydroxychloroquine for COVID-19: The Infusion of Politics Into Science.
33197384 2020. Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.
33210338 2020. Hydroxychloroquine Controversies: Clinical Trials, Epistemology, and the Democratization of Science.
33236703 2020. The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
33243609 2020. Hydroxychloroquine for COVID-19: Balancing contrasting claims.
33254507 2020. It is time to drop hydroxychloroquine from our COVID-19 armamentarium.
33263947 2020. Rise and Fall: Hydroxychloroquine and COVID-19 Global Trends: Interest, Political Influence, and Potential Implications.
33295289 2020. Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
C7305893 ?. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
C7725088 ?. Potential harm caused by physicians a-priori beliefs in the clinical effectiveness of hydroxychloroquine and its impact on clinical and economic outcome ? A simulation approach.
32502485 2020. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
32506216 2020. Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase(R).
32647045 2020. Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making.
32738852 2020. Hydroxychloroquin for COVID-19 Why was so much hype?
32788309 2020. Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter.
32837201 2020. Inefficacite et dangerosite potentielle de l'hydroxychloroquine pour traiter une infection par le coronavirus Sars-cov2.
32848158 2020. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.
32848774 2020. Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use.
32904117 2020. Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety.
32905939 2020. No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials".
32981089 2020. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.
32740071 2020. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
32997483 2020. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
33090972 2020. Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.
33096242 2020. Has the door closed on hydroxychloroquine for SARS-COV-2?
33219663 2020. The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
33219675 2020. Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.
33221868 2020. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
C7298480 2020. Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19. |
C7323099 ?. Hydroxychloroquine for COVID?19: Myths vs Facts.
33082565 2020. HCQ use not protective against SARS-CoV-2.